{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:47Z","timestamp":1761100967034},"reference-count":9,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.transproceed.2008.08.111","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T05:56:46Z","timestamp":1226987806000},"page":"3046-3048","source":"Crossref","is-referenced-by-count":6,"title":["Preliminary Experience With Conversion From Calcineurin Inhibitors to Everolimus in Cardiac Transplantation Maintenance Therapy"],"prefix":"10.1016","volume":"40","author":[{"given":"J.A.","family":"S\u00e1nchez-Brotons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Sobrino-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lage-Gall\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Romero-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guisado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jim\u00e9nez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Benezet-Mazuecos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Ariz\u00f3n-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Mogoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2008.08.111_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.08.111_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcp.1041540103","article-title":"Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle","volume":"154","author":"Tereda","year":"1993","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.transproceed.2008.08.111_bib3","doi-asserted-by":"crossref","first-page":"500S","DOI":"10.1016\/j.transproceed.2004.01.059","article-title":"Experience with everolimus","volume":"36","author":"Augustine","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.08.111_bib4","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.healun.2003.11.029","article-title":"Favourable effect of everolimus on cardiac allograft vasculopathy is maintained through 24 months","volume":"23","author":"Tuzcu","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2008.08.111_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2008.08.111_bib6","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Inmunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from postransplant lymphoproliferative disorder at allograft-protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.08.111_bib7","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1600-6143.2004.00601.x","article-title":"Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure effect modelling","volume":"4","author":"Starling","year":"2004","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2008.08.111_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.healun.2005.01.010","article-title":"Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference","volume":"24","author":"Hummel","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.transproceed.2008.08.111_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1053-2498(02)01221-4","article-title":"Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure","volume":"22","author":"Kovarik","year":"2003","journal-title":"J Heart Lung Transpl"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508011895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508011895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T04:21:51Z","timestamp":1545625311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134508011895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0041134508011895"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2008.08.111","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}